Autocrine and Exocrine Regulation of Interleukin-10 Production in THP-1 Cells Stimulated withBorrelia burgdorferiLipoproteins
- 1 April 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (4) , 1881-8
- https://doi.org/10.1128/iai.70.4.1881-1888.2002
Abstract
We have recently demonstrated that interleukin-10 (IL-10), produced by THP-1 monocytes in response to Borrelia burgdorferi lipoproteins, dampens the production of concomitantly elicited inflammatory cytokines. Thus, IL-10 could potentially down-regulate inflammatory and microbicidal effector mechanisms of the innate immune response to a B. burgdorferi infection, facilitating the establishment of the spirochete. To understand the mechanism(s) implicated in the regulation of the synthesis and release of IL-10 during early infection, we investigated the autocrine effects of IL-6, IL-12, tumor necrosis factor alpha (TNF-alpha), and IL-10 itself, as well as the exocrine effect of IFN-gamma on the production of macrophage-derived IL-10 with lipoprotein as a stimulant. In addition, in view of the differences in the receptor and signal transduction pathways of lipopolysaccharide (LPS) and bacterial lipoproteins, we also investigated the effects described above with LPS as a stimulant. The THP-1 human monocytic cell line and purified recombinant lipidated OspA (L-OspA) were used as the model target cell and stimulant, respectively. TNF-alpha increased the production of IL-10, as elicited by lipoproteins. The production of IL-10 by THP-1 cells stimulated with L-OspA was autoregulated by a negative feedback mechanism involving the IL-10 receptor (IL-10R). Exogenous IFN-gamma significantly inhibited the production of IL-10. Both autocrine (IL-10) and exocrine (IFN-gamma) inhibition of IL-10 production resulted in an increase in the production of the proinflammatory cytokines IL-6 and IL-12. The same results were obtained when the stimulant was LPS. The results further illustrate that IL-10 may play a pivotal role in Lyme disease pathogenesis. Moreover, the regulation of its production with lipoprotein as a stimulant is indistinguishable from that observed when LPS acts as a stimulant.Keywords
This publication has 63 references indexed in Scilit:
- Interleukin-10 Modulates Proinflammatory Cytokines in the Human Monocytic Cell Line THP-1 Stimulated withBorrelia burgdorferiLipoproteinsInfection and Immunity, 2000
- Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokinesFEMS Immunology & Medical Microbiology, 1997
- Mononeuropathy multiplex in rhesus monkeys with chronic lyme diseaseAnnals of Neurology, 1997
- Animal models of Lyme disease: pathogenesis and immunoprophylaxisTrends in Microbiology, 1994
- Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemiaEuropean Journal of Immunology, 1994
- Interferon gamma inhibits interleukin 10 production by monocytes.The Journal of Experimental Medicine, 1993
- Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.The Journal of Experimental Medicine, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Lyme Borreliosis in Selected Strains and Ages of Laboratory MiceThe Journal of Infectious Diseases, 1990
- Lyme DiseaseNew England Journal of Medicine, 1989